|
|
|
Aflac Incorporated (NYSE: AFL) |
|
|
|
|
Select the Financial Report:
|
|
Select the Period:
|
|
Description of Aflac Incorporated's Business Segments
Aflac Incorporated stands as a prominent provider of supplemental insurance solutions in the United States and Japan, crafting products that serve to complement primary health insurance coverage. The companys diverse offerings can be grouped extensively into segments based on geography and the specific types of products offered. Here is a comprehensive overview of Aflacs insurance products and services:
Aflac U.S. Insurance Products
The U.S. segment primarily targets individuals who already have major medical or primary insurance plans. Aflac's supplemental products aim to assist policyholders in managing out-of-pocket expenses that may arise from medical situations not covered by primary insurance. The key features of Aflac's U.S. offerings include guaranteed-renewable coverage, which ensures that coverage remains active throughout the lifetime of the policyholder.
1. Accident and Disability Insurance:
- Accident Insurance:
Aflac's accident insurance policies are designed to mitigate the financial repercussions of accidental injuries. Key benefits include:
- Lump-sum payouts for accidental death and dismemberment.
- Fixed benefits for specific types of injuries.
- Daily fixed benefits for hospital confinement, ensuring support during hospitalization.
- Optional disability riders enhance basic coverage, providing additional financial security.
- Short-Term Disability Insurance:
This insurance provides a safety net for individuals who are temporarily unable to work due to illness or injury. Aflac offers:
- Flexibility in elimination periods (time before benefits start) and benefit periods (duration of benefits).
- Benefits can last up to two years, catering to the varied needs of policyholders.
Supplemental Health Insurance:
Aflac offers a wide array of supplemental health plans that address costs associated with:
- Hospital stays: Coverage for expenses not paid by the primary insurance.
- Critical illness: Cash benefits that assist policyholders in managing severe health conditions, including cancer.
- Cancer treatment: Specific products designed to cover cancer-related medical expenses.
- These supplemental plans provide cash benefits to be used according to the policyholders discretion, which can include paying deductibles, covering daily living expenses, and funding additional treatments not encompassed by primary insurance.
Aflac Japan Insurance Products
In Japan, Aflac has tailored its product offerings to fit the unique healthcare environment shaped by the national health insurance system. This portfolio addresses specific consumer needs:
1. Medical Insurance:
Aflacs medical insurance products in Japan are specifically designed to cover medical and non-medical expenses not reimbursed by the national health insurance, providing essential support for out-of-pocket costs.
Whole Life and Fixed-Benefit Products:
- EVER:
This whole life fixed-benefit medical product was launched in response to the growing out-of-pocket health expenses due to evolving health regulations. It provides lifelong coverage with fixed benefits, ensuring peace of mind for policyholders regardless of age or health conditions.
- Rider MAX:
Aflac Japan's Rider MAX offers extensive accident and medical/sickness benefits. The products evolution to incorporate whole life coverage has had a significant positive impact on sales, reflecting strong consumer demand for enduring coverage options.
Additional Offerings
Aflac is committed to enhancing customer service and education by providing resources that assist policyholders in understanding their benefits and optimizing their insurance coverage. The companys strategic focus encompasses:
- Regional Marketing: Tailoring product offerings to suit the distinct needs of varying demographics and healthcare environments in both the U.S. and Japan.
- Technology Utilization: Implementing digital tools to streamline claims processing and enhance customer engagement, making interactions easier and more efficient.
- Corporate Responsibility and Community Engagement: Aflac is actively involved in community support initiatives, particularly those centered around cancer research and treatment, which bolster the societal impact of its operations.
In summary, Aflac Incorporated provides an extensive selection of supplemental insurance products that fortify the financial security of policyholders in the U.S. and Japan. The company continually adapts its offerings to reflect the changing healthcare landscape and evolving consumer needs, ensuring that comprehensive support is always available to its customers.
Composition of Aflac Incorporated Revenues by
Segments |
| |
| Aflac Japan |
|
 66.86 % |
of total Revenue |
| Aflac U S |
|
50.65 % |
of total Revenue |
| Corporate and other |
|
9.59 % |
of total Revenue |
Q1 three months ended (Mar 31 2025)
|
| Revenues by Business Segments |
Revenues
(in millions $) |
%
(of total Revenues) |
| Aflac Japan |
2,272.00 |
66.86 % |
| Aflac U S |
1,721.00 |
50.65 % |
| Corporate and other |
326.00 |
9.59 % |
| Total |
3,398.00 |
100 % |
Q1 three months ended (Mar 31 2025)
|
| Revenue Growth rates by Segment |
Y/Y Revenue
% |
Q/Q Revenue
% |
| Aflac Japan |
-8.13 % |
- |
| Aflac U S |
1.29 % |
- |
| Corporate and other |
31.98 % |
- |
| Total |
- |
- |
Q1 three months ended (Mar 31 2025)
|
| Income by Business Segments |
Income
(in millions $) |
%
(Profit Margin) |
| Total |
29.00 |
0.85 % |
Q1 three months ended (Mar 31 2025)
|
| Income Growth rates by Segment |
Y/Y Income
% |
Q/Q Income
% |
| Total |
- |
- |
Annual Report on Aflac Incorporated Divisions, Sales by Country |
| |
| Aflac Japan |
|
51.03 % |
of total Revenue |
| Aflac U S |
|
35.61 % |
of total Revenue |
| Corporate and other |
|
5.32 % |
of total Revenue |
Twelve months ended 2024
|
| AFL s Annual Revenue by Geography and Business Segments |
Sales
(in millions $) |
%
(of total Sales) |
| Aflac Japan |
9,659.00 |
51.03 % |
| Aflac U S |
6,739.00 |
35.61 % |
| Corporate and other |
1,007.00 |
5.32 % |
| Total |
18,927.00 |
100 % |
Twelve months ended 2024
|
| AFL s Annual Income by Country and Business Segments |
Income
(in millions $) |
%
(Profit Margin) |
| Total |
5,443.00 |
28.76 % |
Twelve months ended 2024
|
| Annual Revenue and Income Growth by Country and Business Segments |
% Y/Y Sales Growth |
% Y/Y Income Growth |
| Aflac Japan |
-9.42 % |
- |
| Aflac U S |
1.75 % |
- |
| Corporate and other |
118.91 % |
- |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
